Methylene Blue Spray for Identification of Recurrent Laryngeal Nerve and Parathyroid Gland
Sponsored by Zagazig University
About this trial
Last updated 4 years ago
Study ID
Methylene blue
Status
Completed
Type
Interventional
Phase
N/A
Placebo
No
Accepting
16+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 4 years ago
What is this trial about?
Thyroidectomy is the procedure by which surgeons treat various thyroid diseases and is
considered the commonest endocrinal surgery. Yet, it carries a risk for intraoperative
complications. The most distressing complications are recurrent laryngeal nerve and
parathyroid injuries. Methylene blue spray is a technique than can be used for easy
identification of both recurrent laryngeal nerve and parathyroid glands so we can avoid their
injuries.
What are the participation requirements?
Inclusion Criteria
- Age of 16 years and older.
- Both sexes.
- Patients who are candidate for thyroid surgery and euthyroid.
Exclusion Criteria
- - Patients with hyper- or hypo-thyroid status.
- Patients who were unfit for surgery.
- Patients with unilateral or bilateral vocal cord palsy on preoperative indirect laryngoscopy
- Patients with thyroid malignancy by preoperative FNAC.
- Patients with hypersensitivity to methylene blue were excluded.